FBP vaccine: Additional Phase IIa data

Additional data from 51 HLA-A2-positive patients with endometrial or ovarian cancer in the Phase IIa portion of an open-label, U.S. Phase I/IIa trial showed that 6 monthly injections of 100, 500 or 1,...